Aligos Therapeutics (NASDAQ:ALGS) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here's what investors need to know before the announcement.

Analysts estimate that Aligos Therapeutics will report an earnings per share (EPS) of $-0.27.

Aligos Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.06, which was followed by a 1.36% increase in the share price the next day.

Here's a look at Aligos Therapeutics's past performance and the resulting price change:

Stock Performance

Shares of Aligos Therapeutics were trading at $0.8401 as of March 08. Over the last 52-week period, shares are down 38.98%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Aligos Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.